The world is small, and technology has shown us how easily our data crosses borders. In that tradition, I headed over to Health 2.0 Europe to learn a very small amount about the digital health landscape across the Atlantic. Here are some of the highlights.
Trend #1: Symptom Trackers
At this year’s Health 2.0 Europe, more than a few companies presented their ‘symptoms checker’ apps geared toward either physicians or patients. One in particular, Mediktor, hosted a presentation on their clinical trial results, noted to be the first for this type of app. They enrolled 1015 patients (622 included) triaged at levels 3-5 in a large tertiary ED and used their app to determine possible diagnoses. Data collected by an independent researcher compared the ED physician’s diagnosis versus the Mediktor’s pre-diagnosis. The results showed an accuracy of 91.3% for the diagnosis being in the top ten results and 75.4% were in the top 3. While a list of ten seems long, it can aid in considering less likely diagnoses that may be missed. Mediktor partner Josep Carbó acknowledged that his app was not a replacement for physicians but a “tool for professionals.” He also noted that the way forward for the entire field will be more research and quality measures and is looking to further partner with other academic centers interested in working on it.
Our Two Cents: As Jefferson is also involved in telehealth research, we acknowledge this part of the tech revolution might not be as ‘fun’ but will be a necessary step in our evolution and adoption.
Trend #2: New Applications for Artificial Intelligence
Artificial Intelligence solutions had a predictably large presence at Health 2.0 Europe. Aidence, a radiology service based in the Netherlands, pitched their app which helps radiologists diagnose pulmonary nodules on CT scans of the chest. COO Jeroen van Duffeln stated that the statistics show that radiologists can miss approximately 35% of nodules. The AI, on the other hand, missed between 4-20%. The company hopes that earlier diagnosis can decrease deaths from lung cancer. It can also be used to monitor lesions already being treated or monitored for comparison.
Our Two Cents: While the use of AI to find pulmonary nodules is here, the reality is that most pulmonary nodules are not cancerous. What will an increased finding of nodules do to the burden of testing and screening? What will be the number needed to save a life? Sometimes more data becomes unwieldy rather than helpful and having a frank discussion with providers can help bridge this gap.
Wish I could have gotten to everyone – thanks for being a gracious host, Barcelona!
Beyond Silicon Valley
Eight European Health Tech Startups to Watch
With a mission of helping people deal with – or avoid – arthritis, Arthro is in the early stages of using A.I. to formulate exercise regimes.
This Italian company uses brain waves to allow its users to control a computer; can be used by patients with ALS or diseases that cause ‘locked-in’ syndrome for communication.
Wireless EEG and brain stimulation device to monitor brain health with use cases to treat neuropathic pain, epilepsy, depression.
This UK-based app allows patients to find the right sexual health clinic or service nearby – from testing, to contraception to sexual assault support service.
This women’s health app tracks habits, sleep, diet, sex, and gives tips and exercises to help combat pelvic floor weakness as well as other complaints. Watch for great things from CEO Helena Torras.
Network of patients with diabetes and caregivers for questions, support and help with management.
Helps insurance companies find the digital and mobile health technologies best for their users.
Sensor placed into the toilet to measure urine parameters to assess hydration status.